Smart Healthcare Products Market Share Value Projected to Expand by 2018-2026

Smart Healthcare Products Market.png
Smart healthcare products are technology-based products, which offers benefit of advancements in IT hardware and software for better healthcare delivery. They are emerging set of products with positive prospects in near future due to increasing amalgation of information technology in health offerings services. They could save on ever-growing health care cost by imparting operational efficiency and could bring better clinical outcome with monitoring tools such as smart pill etc.

Market Dynamics

Increasing number of people above age 60 worldwide leads to higher requirement of healthcare needs with more emphasis on long term care and chronic disease care, which is one the major drivers for growth of the market. Developed economies such as U.S. and Europe are witnessing high number of population ageing 65 and above. According to the U.S. Census Bureau’s report of 2017, around 47.8 million people were aged 65 and older in the U.S. in 2015 accounting for 14.9% of the total population, a 1.6 million increase from 2014. Europe is currently having highest 65 years and above age population, which is 25% of entire population, according to the Population Prospect Report of the United Nations published in 2017. Smart pill and smart syringe would prove to be important smart healthcare products platform for this population. Another important factor for growth of the smart healthcare products market would be high technological penetration in the smart healthcare products market domain. For instance, cloud-based electronic medical record, which could be shared amongst entire healthcare stakeholders would make entire health operation smooth and efficient.

Increasing number of geriatric population and high prevalence of chronic disease for various parameters is expected to propel growth of the smart healthcare products market

Population across globe is slowly observing growth in median age with higher number of people crossing age bracket of 60 and above. According to the Population Prospects Report of United Nations published in 2017, an estimated 962 million people were aged 60 or over in the world (13 per cent of the global population) in 2017. The population aged 60 or above is growing at a rate of around 3% annually and it is estimated to reach 1.4 billion by 2030. Such high number of aging population would be immensely benefitted with smart healthcare products.

Furthermore, high prevalence of the chronic disease and need for continuous monitoring is expected to drive growth of the market during the forecast period. According to the World Health Organization (WHO) data, in 2017, around 40 million people die annually due to chronic disease, which accounted for 70% of all deaths worldwide. Cardiovascular diseases is responsible for 17.7 million death annually, followed by cancers (8.8 million deaths), respiratory diseases (3.9million deaths), and diabetes (1.6 million deaths).

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/1982

High penetration of smartphone, digital technology, and new products launches to drive growth of the smart healthcare products market

Increased user base of smartphones and tablets across globe especially in emerging economies is expected to increase adoption of smart healthcare products. According to statistics provided by the Pew Research Centre in 2016, around 72% population of the U.S. has smartphone access, around 59% of Chinese population and around 45% of Indian population carries smartphone. The number of internet users in India is expected to reach 450-465 million by 2020, as per estimation of the Internet and Mobile Association of India in 2017.

Global Key Players:

Key players operating in smart healthcare products market include Allscripts Healthcare Solutions Inc. Medtronic, Inc., Becton Dickinson & Company, Honeywell Life Care Solutions, AirStrip Technologies, Cerner Corporation, Stanley Healthcare, Terumo Corporation, Olympus Corporation, and eClinicalWorks.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments

Post a Comment

Popular posts from this blog

Why the Cold Pain Therapy is a Growing Payer Opportunity?

Image
Cold pain therapy is a therapeutic application of cold, used in the treatment of acute soft tissue injuries and to reduce the pain in post-operative condition in orthopedic surgeries, treatment of benign and malignant lesions, and in pain management. Cryotherapy can be applied topically (on the skin surface), surgically or percutaneously. This can also be used to treat various skin conditions such as oral mucositis and tumors in the liver, kidney, bones, breasts and lungs, skin tumors, skin tags, pre-cancerous skin moles, and injuries. Cryosurgery procedure involves use of extreme cold, produced with help of liquid nitrogen (or argon gas) to destroy abnormal tissues. According to the National Cancer Institute (NCI), cryosurgery is used for treatment of several types of cancers and some non-cancerous conditions. It is reported to be effective for treatment in early stage skin cancer, retinoblastoma, actinic keratosis, and cervical intraepithelial neoplasia. Accord...
Read more

Ursodeoxycholic Acid Market Shows Boosted Growth Rate 2018-2026 Estimated by Global Top Players

Image
Ursodeoxycholic acid (UDCA) is a bile acid taken as either a tablet or liquid to treat gallstones and to treat and prevent the progression of cystic fibrosis-related liver disorder. UDCA modifies the bile acid pool by decreasing levels of hydrophobic bile acids while increasing proportion of nontoxic hydrophilic bile acids. UDCA can delay development of gastroesophageal varices and progression to cirrhosis. Moreover it can improve long-term survival in patients with primary biliary cirrhosis. Significant improvement in liver health can be achieved during UDCA therapy in patients with intrahepatic cholestasis of pregnancy, primary sclerosing cholangitis, nonalcoholic fatty liver disease, cystic fibrosis-associated liver disease, total parenteral nutrition-induced cholestasis, graft related liver disease, and in some pediatric cholestatic liver diseases. The global ursodeoxycholic acid market size was valued at US$ 346.2 million in 2017, and is expected to witn...
Read more

Booms and Busts in Anatomic Pathology Market; Dynamics Trends Over The Time Discussed 2018-2026

Image
Anatomic pathology involves direct visualization of human tissue as gross examination as well as under a microscope for proper diagnosis of the disease or a pathological condition. Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial pathology, cytopathology, molecular pathology, and forensic pathology. Procedures performed in anatomic pathology include gross examination, histopathology, immunohistochemistry, in situ hybridization, cryopathology, tissue cytogenetics, and others. Standard approach in anatomical pathology is microscopic examination of tissue samples with the help of one or more stains. Manufacturers have developed stains to identify and classify microorganisms in biopsy of tissue samples or excisional specimens. Various gram stains and acid-fast stains have applications in detection of bacteria and mycobacteria in tissue samples. Commercially available products include tissue processing systems, microtomes, cryostats, ...
Read more